Enlivex Therapeutics Ltd (NASDAQ:ENLV)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ENLV

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ENLV

  • Market Cap$171.340m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINIL0011319527

Company Profile

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.Bioblast Pharma Ltd is a clinical stage biotechnology company. It is engaged in the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases.

Latest ENLV news

Currently there for this company. Visit our news hub for other news .